[Feasibility and technical problems of sentinel node analysis in melanoma]
- PMID: 17141391
- DOI: 10.1016/j.anplas.2006.09.004
[Feasibility and technical problems of sentinel node analysis in melanoma]
Abstract
Background: Development of the sentinel lymph node (SLN) biopsy the last 10 years has changed surgical approach of solid tumor treatment and particularly of melanoma. The aim of our study was to analyze in our hospital, the feasibility of the SLN biopsy technique in order to define a better prognostic classification of melanomas.
Patients and methods: Between July 1999 and October 2003, 97 patients were included in this study in our center. Criteria for inclusion were cutaneo-mucosal melanoma of Breslow >or=1,5 mm, and/or Clarck >or=IV, and/or ulceration, and/or signs of regression, before any surgical margins.
Results: Lymphoscintigraphy (LS) identified at least 1 SLN in 94 cases/97 (97%), thus permitting intraoperative SLN mapping and sentinel node biopsy of at least 1 lymph node in 88 cases/94 (94%). Failure of the SLN procedure was noted in 9 cases: in 3 cases, no lymph node was individualized by LS, in 1 patient, intraoperative SLN mapping failed to find the previously identified SLN and in 5 cases, a SLN was identified by LS and intraoperative mapping but could not be removed because of its deep location and difficulty of dissection. In 17 patients, removal of one or two "non sentinel lymph node(s)" was (were) made by the surgeon because of its (their) suspected aspect (black or large). Among the 88 patients who had dissection of at least 1 SLN, a micrometastasis was detected by standard histological evaluation and/or immunohistochemical stains in 14 cases (16%) and into a "non SLN" in 2 cases (2,3%). The median follow up of patients was 16 months (1- 48 months). Among the 14 patients with positive SLN, 6 (43%) relapsed. The other eight were in complete remission of their melanoma with a mean follow up of 11,44 months . Among the 74 patients with negative SLN, 7 (9,5%) developed a recurrence. Among the 9 patients in whom any sentinel lymph node have been removed, 3 had a relapse (one in transit than on lymph nodes, and two on lymph nodes).
Conclusion: Our results are in accordance with the literature, and confirm the feasibility of SLN mapping and of SLN histological analysis in our center. We described in this study technical problems we encountered. Our study also show the prognostic value of this technique. However, advantage in global survey of sentinel node dissection and regional lymph node dissection in cases of micrometastases has still to be demonstrated.
Similar articles
-
Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.Ann Surg Oncol. 2006 Dec;13(12):1655-63. doi: 10.1245/s10434-006-9066-0. Epub 2006 Oct 3. Ann Surg Oncol. 2006. PMID: 17016755
-
[Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].Ned Tijdschr Geneeskd. 2004 May 1;148(18):884-8. Ned Tijdschr Geneeskd. 2004. PMID: 15152391 Dutch.
-
Intraoperative evaluation of sentinel lymph nodes for metastatic melanoma by imprint cytology.Cancer. 2002 Jun 1;94(11):3016-22. doi: 10.1002/cncr.10512. Cancer. 2002. PMID: 12115392
-
Sentinel lymph node biopsy in patients with Stage I/II melanoma: Clinical experience and literature review.J Surg Oncol. 2004 Mar;85(3):133-40. doi: 10.1002/jso.20026. J Surg Oncol. 2004. PMID: 14991885 Review.
-
Sentinel lymph node biopsy in patients with primary cutaneous melanoma: study of 455 cases.J Eur Acad Dermatol Venereol. 2000 Jan;14(1):35-45. doi: 10.1046/j.1468-3083.2000.00005.x. J Eur Acad Dermatol Venereol. 2000. PMID: 10877250 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical